HPLC-MS is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-01. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
=== Political profile and resignation from PES (2024–present) === In February 2024, Jakov Milatović officially announced his resignation from all leadership positions and membership within the Europe Now Movement (PES), a centrist party he had co-founded in mid-2022 alongside Prime Minister Milojko Spajić. In his public statement, Milatović cited fundamental differences regarding party governance, transparency, internal democracy, and a perceived departure from the movement's original values and policy promises. Following his resignation, Milatović declared his intent to act as a fully non-partisan, independent President, positioned above party politics to ensure institutional balance, uphold constitutional norms, and serve as a unifying head of state for all citizens. Operating as an independent president, Milatović frequently exercised his constitutional prerogative of the suspensive veto by returning legislation passed by the Parliament of Montenegro for reconsideration. His vetoes targeted key statutes concerning taxation, fiscal reform, public security, and local government management, where he expressed concerns regarding long-term macroeconomic stability, constitutional compliance, and alignment with European standards. Milatović consistently emphasizied the need to depoliticize local public administrations and focus on community-level economic development.
Initial letters are used where there is no ambiguity: C cysteine, H histidine, I isoleucine, M methionine, S serine, V valine. No other amino acids in this set begin with each of those letters. Where arbitrary assignment is needed, the structurally simpler amino acids are given precedence: A alanine, G glycine, L leucine, P proline, T threonine. For example, alanine is simpler than arginine or asparagine, the other amino acids starting with "a". F PHenylalanine and R aRginine are assigned by being phonetically suggestive, W tryptophan is assigned based on the double ring being visually suggestive to the bulky letter W, K lysine and Y tyrosine are assigned as alphabetically nearest to their initials L and T (note that U was avoided for its similarity with V, while X was reserved for undetermined or atypical amino acids); for tyrosine the mnemonic tYrosine was also proposed, D aspartate was assigned arbitrarily, with the proposed mnemonic asparDic acid; E glutamate was assigned in alphabetical sequence being larger by merely one methylene –CH2– group, N asparagine was assigned arbitrarily, with the proposed mnemonic asparagiNe; Q glutamine was assigned in alphabetical sequence of those still available (note again that O was avoided due to similarity with D), with the proposed mnemonic Qlutamine.
α-ketoglutarate + AcCoA → homocitrate → L-α-aminoadipic acid → L-lysine + β-lactam The Penicillium cells are grown using a technique called fed-batch culture, in which the cells are constantly subjected to stress, which is required for induction of penicillin production. While the usage of glucose as a carbon source represses penicillin biosynthesis enzymes, lactose does not exert any effect and alkaline pH levels override this regulation. Excess phosphate, available oxygen, and usage of ammonium as a nitrogen source repress penicillin production, while methionine can act as a sole nitrogen/sulfur source with stimulating effects. The biotechnological method of directed evolution has been applied to produce by mutation a large number of Penicillium strains. These techniques include error-prone PCR, DNA shuffling, ITCHY and strand-overlap PCR.
Sources: en.wikipedia.org
== Interpreting results == The Ka/Ks ratio is used to infer the direction and magnitude of natural selection acting on protein coding genes. A ratio greater than 1 implies positive or Darwinian selection (driving change); less than 1 implies purifying or stabilizing selection (acting against change); and a ratio of exactly 1 indicates neutral (i.e. no) selection. However, a combination of positive and purifying selection at different points within the gene or at different times along its evolution may cancel each other out. The resulting averaged value can mask the presence of one of the selections and lower the seeming magnitude of another selection. Of course, it is necessary to perform a statistical analysis to determine whether a result is significantly different from 1, or whether any apparent difference may occur as a result of a limited data set. The appropriate statistical test for an approximate method involves approximating dN − dS with a normal approximation, and determining whether 0 falls within the central region of the approximation. More sophisticated likelihood techniques can be used to analyse the results of a Maximum Likelihood analysis, by performing a chi-squared test to distinguish between a null model (Ka/Ks = 1) and the observed results.
Bacteriophages: Microbiology, Bacteriophages, RNA polymerases, Structural Biology, Biochemistry (Maria Sokolova) Cell and Virus Structures: Structural Biology, Cryo-Electron Tomography, Viruses, Membrane trafficking (John Briggs) Cell Dynamics: Phagocytosis, Actin Dynamics, Cell Motility (Günther Gerisch) Cellular and Molecular Biophysics: Biophysics, Fluorescence Correlation Spectroscopy, Atomic Force Microscopy, Single Molecule, Synthetic Biology (Petra Schwille) Cellular Biochemistry: Molecular Chaperones, Protein Folding, Protostasis, Aging and Neurodegenerative Diseases (Franz-Ulrich Hartl) Chaperonin-assisted Protein Folding: Protein Folding and Assembly, Rubisco, GroEL and GroES, Mass Spectrometry (Manajit Hayer-Hartl) Chromatin Biology: Genetics and Biochemistry of Chromatin, Transcription, Histone Modifications, Drosophila Development (Jürg Müller) Chromosome Biology: Cell division, Meiosis (Wolfgang Zachariae) Computational Systems Biochemistry: Systems Biology, Proteomics, Mass Spectrometry, Bioinformatics (Jürgen Cox) CryoEM Technology: Cryo-Electron Tomography, Focused Ion Beam Milling, correlated light microscopy, in situ Structural Biology, visual Proteomics (Jürgen Plitzko) DNA Hybridnanomaterials: DNA Nanotechnology, DNA-Silica Hybridnanomaterials, Bionanotechnology, Biophysics (Amelie Heuer-Jungemann) Immunoregulation: Immunity, Macrophage: T cell cross-talk, Self-Tolerance, Amino Acid metabolism (Peter Murray) Machine Learning and Systems Biology: biomedical research, data mining, machine learning, biological systems (Karsten Borgwardt) Mechanisms of Protein Biogenesis: RNA Biology; Translation Dynamics; Protein Folding; Systems Biology (Danny Nedialkova) Molecular Imaging and Bionanotechnology: Super-Resolution Microscopy, DNA Nanotechnology, Biophysics, Single-Molecule Studies (Ralf Jungmann) Molecular Machines and Signaling: Structural Biology, Ubiquitin Proteasome System, Ubiquitin-like Proteins (Brenda Schulman) Molecular Medicine: Integrin, Adhesion Signalling, Mouse Genetics (Reinhard Fässler) Molecular Structural Biology: Cryo-Electron Tomography, Electron Microscopical Structure Research, Protein and Cell Structure, Protein Degradation (Wolfgang Baumeister) Proteomics and Signal Transduction: Mass Spectrometry, Systems Biology, Bioinformatics, Cancer (Matthias Mann) Structural Cell Biology: Structural Studies, RNA Transport, RNA Surveillance, RNA Degradation (Elena Conti) Structure and Dynamics of Molecular Machines: DNA Replication Dynamics, Structural Biology, Single-Molecule Imaging, Biophysics (Karl Duderstadt) Structure Research: Structural Biology, Methods of Protein Crystallography, Protein Degradation, Medicinal Chemistry (Robert Huber) Totipotency: Mechanistic Cell Biology, Genomics and Biochemistry of Chromatin Reprogramming, Transcription, Mouse Genetics (Kikuë Tachibana) Translational Medicine: Fibronectin, Integrin, Bone, Disease (Inaam Nakchbandi)
== Nuclear fuel == Uranium-233 has been used as fuel in several reactor types and has been proposed for use in new designs. Uranium-233 can be bred in either fast reactors or thermal reactors, unlike the uranium-238-based fuel cycles which require the superior neutron economy of a fast reactor in order to breed plutonium, that is, to produce more fissile material than is consumed. In 1968, the Molten-Salt Reactor Experiment at Oak Ridge became the first reactor to operate on uranium-233. The long-term strategy of the nuclear power program of India, which has substantial thorium reserves, is to move to a nuclear program breeding uranium-233 from thorium feedstock.
This concept is of clinical interest as it is sometimes necessary to reach a certain concentration of a drug that is known to be optimal in order for it to have the required effects on the organism (as occurs if a patient is to be scanned).
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.